Fairvalue-Calculator Fairvalue-Calculator
EN DE

Mont Royal Resources Limited (MRZ) Fair Value & Analysis

Basic Materials · AU · Market cap A$42.3M

PriceA$0.1350
Fair ValueA$0.1000
Upside-25.9%
Quality84/100
Evidence: Low Range A$0.0800 – A$0.1300

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Mont Royal Resources Limited (MRZ) currently trades at A$0.1350, while our model-based Fair Value estimate is A$0.1000 — implying the stock looks roughly 25.9% overvalued today. We read business quality at 84/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Mont Royal Resources Limited engages in the development and exploration of minerals properties in Canada. The flagship property includes 100% interest in the Ashram rare earth and fluorspar deposit in Québec, Canada. Mont Royal Resources Limited is based in Sydney, Australia.

Open the full interactive analysis →

Similar stocks

BHP Group (BHP) -27% Rio Tinto Group (RTNTF) -41% Grupo México, S.A. (GMBXF) -6% CMOC Group (CMCLY) -24% Vale S.A (VALEN) -96% Anglo American plc (AAUKF) -61%

Frequently asked questions

Is Mont Royal Resources Limited (MRZ) undervalued?
As of Jun 24, 2026, our model estimates a fair value of A$0.1000 versus a price of A$0.1350 — about −26% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MRZ?
Our 21-model fair value for Mont Royal Resources Limited is A$0.1000 (as of Jun 24, 2026), built from audited fundamentals. The current price is A$0.1350.
What is the quality score of MRZ?
Mont Royal Resources Limited has a Quality Score of 84/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.